• Comp Report
  • VC Report
  • Biz Report
  • About
  • Unsubscribe/Subscribe
  • Links
Menu

Bullseye Consulting Group

Street Address
City, State, Zip
770-315-6331
executive compensation - venture capital - news

Your Custom Text Here

Bullseye Consulting Group

  • Comp Report
  • VC Report
  • Biz Report
  • About
  • Unsubscribe/Subscribe
  • Links

COVID vaccine manufacturer taking 'go forward' approach to shots

September 1, 2021 Robert Harrington

John Chiminski, the CEO of Catalent Pharma Solutions, which manufactures COVID-19 vaccines for Moderna, Johnson & Johnson and AstraZeneca, described last year’s supply chain challenges and how his company overcame them. He also provided insight as to how his company is preparing for increased expected demand as booster shots gain traction. READ MORE

← Google pushes its return to the office back to 2022White House COVID-19 czar urges businesses require employees to be vaccinated →

rharrington@bullseye.consulting

       @BobJHarrington